Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,714 across all filing types
Latest filing 2018-10-12 Earnings Release
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
2018年前三季度业绩预告
Earnings Release Classification · 95% confidence The document is a performance forecast for the first three quarters of 2018, providing estimated net profit and earnings per share figures, explicitly stating that the data is preliminary and unaudited. It mentions that detailed financial data will be disclosed in the upcoming third quarter report. The document is short (920 characters) and serves as an announcement of expected financial results rather than a full financial report. This fits the definition of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. 9M 2018
2018-10-12 Chinese
关于参加2018年湖南辖区上市公司投资者网上接待日活动的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (676 characters) about the company's participation in an investor online reception day event organized by regulatory and industry bodies. It mentions the event date and the topics to be discussed, such as company governance, business development, financing, and sustainability. There is no financial data, no detailed report, no voting results, no management changes, or other specific filings. The document serves as a public notice to investors about an upcoming event rather than a report or detailed filing. It fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit other specific categories.
2018-09-03 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a stock trading abnormal fluctuation announcement by the company 启迪古汉集团股份有限公司. It discusses unusual stock price movements over specific dates, explanations about ongoing corporate actions such as a planned equity restructuring and a proposed acquisition, and confirms no undisclosed material information affecting stock price. It also references the publication of the company's 2018 semi-annual report but does not contain the report itself. The document is relatively short (2080 characters) and serves as a regulatory disclosure about stock price volatility and related corporate events. This fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2018-08-28 Chinese
独立董事对第八届董事会临时会议相关议案的独立意见
Audit Report / Information Classification · 90% confidence The document is an independent opinion from independent directors regarding specific board meeting proposals, focusing on the review of related party transactions, guarantees, and the use of raised funds for the half-year period ending June 30, 2018. It references regulatory guidelines and provides an independent opinion on the company's half-year fundraising usage report. The document is not a full financial report but rather an independent directors' review and opinion on specific matters discussed in a board meeting. It does not contain comprehensive financial statements or detailed financial analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). It is also not a simple announcement or certification but a formal independent opinion related to governance and compliance matters. Therefore, the best fitting category is Audit Report / Information (AR), as it involves audit-related opinions and compliance with regulatory requirements regarding financial matters and internal controls. H1 2018
2018-08-28 Chinese
第八届监事会临时会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of the resolutions passed at the company's eighth Supervisory Board interim meeting. It specifically mentions the review and approval of the company's 2018 semi-annual report and a special report on the use of raised funds. The document is short (800 characters) and serves as a notice of the meeting's decisions rather than containing the full semi-annual report or detailed financial data. It also includes voting results and compliance statements. According to the 'Menu vs Meal' rule, since this is an announcement of the approval of the semi-annual report and related special report rather than the reports themselves, it should be classified as a Regulatory Filing (RNS).
2018-08-28 Chinese
第八届董事会临时会议决议公告
Report Publication Announcement Classification · 95% confidence The document is a board resolution announcement from the company's eighth board meeting held on August 28, 2018. It states that the board approved the company's 2018 semi-annual report and a special report on the use of raised funds. However, the document itself does not contain the full semi-annual report or the special report; it only announces the approval and refers to the full reports disclosed on the same day. The document length is short (555 characters), and it serves as an official announcement of board decisions rather than the report itself. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA) rather than the actual Interim/Quarterly Report (IR).
2018-08-28 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.